Breaking Through the Norm With Innovation

Chief Executive Officer, Board Member

Jensen is a market leader in delivering operational excellence and driving profitable growth. In his previous role as Chief Executive Officer of TearLab, he led the company through a complete corporate and commercial restructure, cutting costs over 40% and growing the customer base by more than 25% before successfully completing the organization’s acquisition, privatization, and recapitalization. As CEO of Balance Ophthalmics, Jensen brings his 25+ years of experience across multiple boards and C-suite positions in launching disruptive technology and managing scale against growth and profit objectives.

Chief Commercial Officer

Norbert Lowe is a seasoned commercial leader with more than 30 years of sales, marketing, and operations experience across the ophthalmic and broader healthcare industries. Throughout his career, he has held leadership roles at Eyenovia, Aerie, Carl Zeiss Meditec, AcuFocus, Boston Scientific, and Inspire Pharmaceuticals. As SVP of Commercial Operations at Eyenovia, he led commercial strategy for the Optejet® microdose platform and has played a key role in bringing innovative technologies to market across glaucoma, presbyopia, dry eye, bacterial conjunctivitis, and myopia. He also brings extensive experience building and scaling sales teams in emerging companies. Since June 2026, Lowe has served as Chief Commercial Officer of Balance Ophthalmics. He holds a B.Sc. in Psychology and Economics from the University of California, Irvine.

Chief Technology Officer

Enrico Brambilla joined Balance Ophthalmics as Chief Technology Officer in April 2026. He has led product development for numerous medical devices, from concept creation through FDA clearance/approval and market launch, and holds numerous international patents. Previously, Enrico served as SVP of Product Research and Development at Eyenovia, VP of R&D and Manufacturing at Equinox Ophthalmics, and Engineering Lead at Breathe Technologies. He began his engineering career at Electrolux Home Products in Europe before moving to ResMed in Australia.

Chief Business Officer

As Chief Business Officer of Balance Ophthalmics, Justin Kelly brings 25 years of healthcare experience, from clinical nursing to commercializing first-in-class medical devices in neuromodulation, ophthalmology, musculoskeletal care, and neurology, with expertise in Medicare DMEPOS reimbursement, HCPCS Level II coding, and U.S. and European payer policy. He founded Persolvis LLC, a medtech and biotech market access advisory, and holds a nursing degree from the University of Massachusetts Boston and a Master of Global Business Administration from Tufts University.

Founder & Chair

A board-certified ophthalmologist who is fellowship-trained in cornea, glaucoma, and refractive surgery, Dr. Berdahl specializes in treating anterior segment conditions with innovative solutions. He co-invented the MKO melt (IV-free sedation for cataract surgery without opioids) and co-founded astigmatismfix.com (a tool that assists cataract surgeons in eliminating residual astigmatism), as well as ExpertOpinion.MD for patients to request medical opinions from world experts, and a rare-disease drug company.

Executive Chairman

Raetzman has extensive leadership experience across multiple healthcare categories, having served in senior executive positions for Nestlé Skin Health, Galderma, and Alcon. He lived in the US and in Europe while leading global businesses, and has more than 20 years of specialized eye care leadership experience. Raetzman has also served as a Board Member at TearClear, an ophthalmic pharmaceutical company specializing in preservative-free therapies.

Board Member

As the President of Phillips Consulting Group, LLC, Mr. Phillips brings more than 3 decades of experience in FDA regulation of medical devices. His extensive knowledge of regulatory matters includes FDA jurisdiction, device classification, clinical trials, and product labeling. His previous roles include the Office of Device Evaluation’s Deputy Director for Science and Regulatory Policy for 12 years and the Chief of the Surgical and Diagnostics Devices Branch in DOD.

Board Member

Currently serving as CFO of Sight Sciences®, a medical device company specializing in eye diseases, Bauerlein has extensive experience in strategic healthcare business development, from start-ups to public companies. She co-founded Inogen, a leading global medical technology company, and has served as Board Member for multiple therapeutics companies, as well as Koya Medical, a private healthcare company focused on breakthrough treatments for venous and lymphatic diseases.

Board Member

Matt Larson has over a decade of experience in the ophthalmic sector with roles on the clinical research side as well as several positions with a commercial focus. Larson has been involved in multiple aspects of medical device companies. He was responsible for launching the KAMRA corneal inlay in the Asia-Pacific and played an executive role in acquiring US approval, making KAMRA the first US-approved corneal inlay for presbyopia. Larson also led the launch of the IC-8 intraocular lens in Europe and the Asia-Pacific.